IDEXX Laboratories, Inc.
IDXX
$579.85
$2.730.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.09B | 1.11B | 1.11B | 998.43M | 954.29M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.09B | 1.11B | 1.11B | 998.43M | 954.29M |
| Cost of Revenue | 432.47M | 421.89M | 414.73M | 375.05M | 383.63M |
| Gross Profit | 658.11M | 683.35M | 694.73M | 623.38M | 570.66M |
| SG&A Expenses | 266.68M | 265.09M | 259.79M | 247.78M | 251.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 765.97M | 750.39M | 736.41M | 681.89M | 692.60M |
| Operating Income | 324.61M | 354.85M | 373.05M | 316.53M | 261.69M |
| Income Before Tax | 306.98M | 344.77M | 362.35M | 310.08M | 256.39M |
| Income Tax Expenses | 58.79M | 70.16M | 68.36M | 67.41M | 40.24M |
| Earnings from Continuing Operations | 248.19M | 274.61M | 293.99M | 242.68M | 216.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 248.19M | 274.61M | 293.99M | 242.68M | 216.15M |
| EBIT | 324.61M | 354.85M | 373.05M | 316.53M | 261.69M |
| EBITDA | 363.33M | 391.47M | 408.82M | 350.60M | 295.39M |
| EPS Basic | 3.11 | 3.43 | 3.66 | 2.98 | 2.64 |
| Normalized Basic EPS | 2.47 | 2.69 | 2.82 | 2.38 | 1.96 |
| EPS Diluted | 3.09 | 3.40 | 3.63 | 2.96 | 2.62 |
| Normalized Diluted EPS | 2.45 | 2.67 | 2.80 | 2.37 | 1.94 |
| Average Basic Shares Outstanding | 79.90M | 80.10M | 80.41M | 81.32M | 81.85M |
| Average Diluted Shares Outstanding | 80.48M | 80.68M | 80.99M | 81.92M | 82.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |